Haemostatic and replacement therapy in von Willebrand disease Journal Articles

abstract

• A variety of haemostatic agents can be helpful for patients with von Willebrand disease in case of bleeding. There are orally administered substances, such as tranexamic acid, oestrogens and prednisone; agents for topical or local use; and medicines for injection or infusion, including desmopressin, blood plasma products and recombinant activated factor VII. The choice depends on the type of haemorrhage, the severity of the disease, presence of inhibitors, availability and cost. Some of these aspects are reviewed here.

authors

• Schulman, Sam

status

• published 

publication date

• May 1999

has subject area

• 1103 Clinical Sciences (FoR)
• Blood Transfusion (MeSH)
• Cardiovascular System & Hematology (Science Metrix)
• DNA, Recombinant (MeSH)
• Deamino Arginine Vasopressin (MeSH)
• Factor VII (MeSH)
• Hemostasis (MeSH)
• Hemostatics (MeSH)
• Recombinant Proteins (MeSH)
• von Willebrand Diseases (MeSH)

published in

• Haemophilia  Journal

keywords

• Blood Transfusion
• DNA, Recombinant
• Deamino Arginine Vasopressin
• Factor VII
• Hemostasis
• Hemostatics
• Recombinant Proteins
• von Willebrand Diseases

Digital Object Identifier (DOI)

• 10.1046/j.1365-2516.1999.0050s2057.x

PubMed ID

• 23401901

start page

• 57

end page

• 59

volume

• 5

issue

• s2